Huaian Hanyou Peptide
Finnrick has tested 68 samples from Huaian Hanyou Peptide across 7 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| GHK-Cu | 8 | 25 Nov 2025 | 9 Aug 2026 | |||||
| Tesamorelin | 6 | 6 May 2026 | 2 Aug 2026 | |||||
| TB-500 | 4 | 27 Oct 2025 | 17 Jun 2026 | |||||
| BPC-157 | 9 | 14 Oct 2025 | 23 Jul 2026 | |||||
| MOTS-c | 5 | 27 May 2026 | 17 Jul 2026 | |||||
| Retatrutide | 29 | 14 Nov 2025 | 13 Aug 2026 | |||||
| Tirzepatide | 7 | 13 Oct 2025 | 21 Jul 2026 | |||||
The Huaian Hanyou Peptide samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
Based on 70 overall satisfaction reports
People who submitted test requests to Finnrick gave Huaian Hanyou Peptide an average satisfaction rating of 3.9 out of 5 across 70 reports associated with samples received and tested by Finnrick. Customers rated delivery speed (3.0/5) comparatively lower.
Most recent Huaian Hanyou Peptide tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 13 Aug 2026 | Retatrutide | View | 30mg | 28.3mg | -5.7% | 99.90% | not detected | (no batch ID) | No label / Silver crimp / Pink cap | Lab E | Public | |
| 9 Aug 2026 | GHK-Cu | View | 50mg | 53.8mg | +7.6% | 99.70% | n/a | Apr. 02, 2026 | (no data) | Lab G | Public | |
| 6 Aug 2026 | Retatrutide | View | 20mg | 23.2mg | +16.0% | 99.80% | n/a | (no batch ID) | No label / Gold crimp / Clear cap | Lab G | Public | |
| 5 Aug 2026 | Retatrutide | View | 10mg | ⚠️ Sample does not contain Retatrutide | low | (no batch ID) | No label, Silver crimp, Yellow cap | Lab E | Public | |||
| 5 Aug 2026 | Retatrutide | View | 10mg | ⚠️ Sample does not contain Retatrutide | n/a | Apr. 02, 2026 | (no data) | Lab E | Public | |||
| 5 Aug 2026 | Retatrutide | View | 5mg | 5.01mg | +0.2% | 99.90% | n/a | Apr 2, 2026 | No label / Silver crimp / Blue cap | Lab E | Public | |
| 3 Aug 2026 | GHK-Cu | View | 100mg | 90.3mg | -9.7% | 99.90% | n/a | Mar 2, 2026 | No label / Silver crimp / Red cap | Lab E | Public | |
Corrections
- 3 Aug 2026: KLOW
- During the initial data capture for sample **bg8dm6r**, the declared potency of **KLOW 80 mg** was recorded incorrectly. The value was subsequently reviewed and manually corrected to match the potency reported in the corresponding Certificate of Analysis (COA). As a result of this correction, the sample score was updated from **3.2** to **7.0**.
About Huaian Hanyou Peptide Test Results From Finnrick
Huaian Hanyou Peptide is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 7 products and 68 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud) and customer satisfaction reports with sub-scores that provide additional context. Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Huaian Hanyou Peptide Testing Activity & Score Summary
In the past 30 days, Finnrick has published 10 new test results for Huaian Hanyou Peptide, and 37 in the past three months. The overall dataset includes 68 tested samples with an average score of 7.0/10 across all products.
Across 68 identity-tested samples, 90% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.9%. Approximately 95% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 3):
- Retatrutide (29 tests, 86% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 0.0 to 10.0 (average 7.4/10), suggesting significant batch-to-batch differences.
- Tesamorelin (6 tests, 100% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 4.3 to 10.0 (average 6.8/10), suggesting significant batch-to-batch differences.
- BPC-157 (9 tests, 89% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 0.0 to 10.0 (average 6.5/10), suggesting significant batch-to-batch differences.